Insider Transactions in Q2 2023 at Oncocyte Corp (OCX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
John Peter Gutfreund |
SELL
Other acquisition or disposition
|
Indirect |
3,085,047
-100.0%
|
-
|
|
Jun 23
2023
|
Lou Silverman Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+44.43%
|
-
|
|
Jun 23
2023
|
Alfred D Kingsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+3.93%
|
-
|
|
Jun 23
2023
|
Andrew J. Last Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+18.15%
|
-
|
|
Jun 23
2023
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+4.09%
|
-
|
|
Jun 14
2023
|
Alfred D Kingsley Director |
BUY
Open market or private purchase
|
Direct |
30,000
+6.01%
|
$0
$0.21 P/Share
|
|
Apr 05
2023
|
Pura Vida Investments, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
663,000
+7.57%
|
$0
$0.3 P/Share
|
|
Apr 03
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Apr 03
2023
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
26,827,638
+34.84%
|
$0
$0.3 P/Share
|
|
Apr 03
2023
|
John Peter Gutfreund |
BUY
Grant, award, or other acquisition
|
Indirect |
1,000,000
+48.19%
|
$0
$0.35 P/Share
|
|
Apr 03
2023
|
John Peter Gutfreund |
BUY
Grant, award, or other acquisition
|
Direct |
705,000
+49.65%
|
$0
$0.35 P/Share
|
|
Apr 03
2023
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Indirect |
282,168
+47.48%
|
$0
$0.35 P/Share
|
|
Apr 03
2023
|
Andrew Arno Director |
BUY
Grant, award, or other acquisition
|
Direct |
141,084
+17.33%
|
$0
$0.35 P/Share
|